Prelude Capital Management, LLC Cara Therapeutics, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.85 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$9.12 - $17.78 $848 - $1,653
-93 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$16.11 - $25.98 $1,498 - $2,416
93 New
93 $1,000
Q1 2019

May 15, 2019
SELL
$14.41 - $19.64 $6,902 - $9,407
-479 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$12.45 - $23.47 $5,963 - $11,242
479 New
479 $6,000

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email